All In Biotech

Drug Trial Radar · NCT03247686

A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome

A Phase 2, Double-blind, Placebo-controlled Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome

Last checked: Nov 20, 2026Latest source record: Apr 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

28

Actual

Start

Feb 1, 2017

Primary completion

Jul 15, 2018

Study completion Aug 1, 2019

Sponsor

Lead sponsor
Resolve TherapeuticsIndustry
Sponsor type
Industry
Collaborators
University Hospital Birmingham; Newcastle-upon-Tyne Hospitals NHS Trust
First posted
Aug 14, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The present study will examine the role of circulating RNA complexed with autoantibodies and immune complexes and its role in activation of inflammatory pathways in patients with primary Sjogren's syndrome. The study will be conducted in a subset of Sjogren's patients who have elevated levels of autoantibodies and a pattern of elevated interferon-stimulated gene expression in blood cells. A number of biochemical and clinical parameters will be analyzed to determine the potential therapeutic utility of nuclease therapy in Sjogren's syndrome.

Conditions

  • Sjogren's Syndrome

Interventions

  • RSLV-132Drug

    RNase Fc fusion protein

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Blood Cell Gene ExpressionTime frame: Day 1 and Day 99

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • University Hospitals Birmingham

    Birmingham, Edgbaston, United Kingdom

  • Newcastle upon Tyne Hospitals

    Newcastle upon Tyne, Gosforth, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.